Discover the BioCeuticals difference today
Quick Answer: Tirzepatide carries an FDA boxed warning for thyroid C-cell tumors based on rodent studies, but clinical trials have not shown increased thyroid nodule or cancer risk in humans over two years of treatment
Specifically, the reduced light sensitivity, quantitative, colorimetric nature, and the capacity for use on dried bloodspots make this method more suitable for field use than the Hirono method
It is a specific molecule with a research history
Most strikingly, multiple trials have now shown that GLP-1 agonists can lead to the resolution of MASH, a severe form of fatty liver disease, without worsening of liver fibrosis, which is a common adverse outcome seen with some current medications
At Vive Ageless Weight Loss, we understand that individual results with liraglutide or Semaglutide GLP-1 can vary significantly